Bio2 has been acquired by Alliando Group
The private shareholders of Bio2, a Portuguese petcare wholesaler, have sold the company to Alliando Group.
Founded in 1984, Bio2 is one of the two largest Portuguese pet wholesalers, with a strong focus on pharmaceutical products to B2B customers: pet shops, veterinary clinics and other specialized retailers. The company has been investing in digital technology and online channels, having launched an e-commerce website for its B2B customers to develop its multichannel offering.
Founded in 1987, Alliando Group is a French family-owned group and the second largest distributor of veterinary products in the European market. It is also the leader in the retail pharmacy, livestock production group and industrial veterinary practice channels. Following a period of strong organic and external growth in France, Alliando started an internationalization strategy in 2015 which resulted in the group’s establishment in Spain, Poland and in several countries in West Africa.
Oaklins’ team in Portugal acted as the exclusive M&A advisor to the shareholders of Bio2. The team was involved throughout the preparation of the sale process and supported all aspects of the negotiation phase until closing.
Pedro Mesquita Gabriel
Shareholder, Bio2
Talk to the deal team
Related deals
AYANDA CAPITAL has added a new investor to its shareholding
A new investor, Thierry Jacobs, has joined AYANDA CAPITAL S.L.’s shareholding with a minority stake.
Learn moreGoldlight has been acquired by Grenardi Group
AS Grenardi Group, the largest Baltic jewelry retailer, has acquired Goldlight.
Learn moreNuzoa has acquired Dinazoo
Spanish private equity-backed Nuzoa, a prominent animal health distributor in Spain, has acquired Dinazoo. This acquisition marks one of the first steps in Nuzoa’s international expansion. It will strengthen Nuzoa’s relationships with key clients who also operate in the Portuguese market, along with its suppliers. This agreement will enhance both companies’ presence in the Portuguese market by gaining access to more advanced technology and expanding their portfolio in key areas of the business.
Learn more